<DOC>
	<DOCNO>NCT00153881</DOCNO>
	<brief_summary>The primary objective determine maximum tolerate dose oral capecitabine , combination fix dose weekly docetaxel , concurrent thoracic radiation treatment patient clinical stage II-III cancer esophagus gastroesophageal junction .</brief_summary>
	<brief_title>Docetaxel Carboplatin Followed Oral Capecitabine , Docetaxel Radiation Esophageal Cancer</brief_title>
	<detailed_description>This dose-ranging trial design establish phase II dose capecitabine safely give docetaxel radiation therapy treatment patient cancer esophagus gastroesophageal junction . The docetaxel dose 15 mg/m2/week , 5-fluorouracil dose 200 mg/m2/week , 50.4 Gy thoracic radiation find recommended dos initial phase I trial ( DMS D9724 ) . The Phase I study modify attempt improve pathological complete response rate increase 5-fluorouracil exposure thoracic radiation replace oral capecitabine . Capecitabine generate 5-fluorouracil selectively tumor cell . This sequentially design study EUS staging , molecular analysis , neoadjuvant chemotherapy , concomitant chemotherapy radiation , surgical resection continue expand collaborative experience Dartmouth Hitchcock treatment cancer esophagus gastroesophageal junction .</detailed_description>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>Esophageal gastroesophageal junction cancer locally advance surgically resectable ( stage II III disease ) . No prior therapy . Adequate organ function . Evidence metastasis ( celiac axis lymph node allow ) . Cervical esophageal tumor . Peripheral auditory neuropathy grade &gt; = 2 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Esophageal Cancer</keyword>
	<keyword>Trimodality</keyword>
	<keyword>Capecitabine</keyword>
	<keyword>Xeloda</keyword>
	<keyword>Gastro-esophageal Neoplasm</keyword>
	<keyword>Carcinoma Esophagus</keyword>
</DOC>